학술논문
Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study
Document Type
Article
Author
Barber, Bridget E; Fernandez, Melissa; Patel, Hardik Babubhai; Barcelo, Catalina; Woolley, Stephen D; Patel, Harilal; Llewellyn, Stacey; Abd-Rahman, Azrin N; Sharma, Sunil; Jain, Mukul; Ghoghari, Ashok; Di Resta, Ilaria; Fuchs, Aline; Deni, Ioanna; Yeo, Tomas; Mok, Sachel; Fidock, David A; Chalon, Stephan; Möhrle, Jörg J; Parmar, Deven; McCarthy, James S; Kansagra, Kevinkumar
Source
In The Lancet Infectious Diseases June 2022 22(6):879-890
Subject
Language
ISSN
1473-3099